C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 498/10 (2006.01) A61K 31/395 (2006.01) A61K 31/675 (2006.01) C07D 261/00 (2006.01) C07D 261/04 (2006.01) C07D 261/10 (2006.01) C07D 413/04 (2006.01) C07D 413/06 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2174838
This invention relates to novel isoxazolines and isoxazoles which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex. to pharmaceutical compositions containing such compounds, processes for preparing such compounds and to methods of using these compounds, alone or in combination with other therapeutic agents for the inhibition of platelet aggregation, as thrombolytics and/or for the treatment of thromboembolic disorders.
L'invention se rapporte à de nouveaux isoxazoles et isoxazolines aptes à être utilisés comme antagonistes du complexe récepteur de fibrinogène/glycoprotéine plaquettaire IIb/IIIa, à des compositions pharmaceutiques contenant ces composés, à des procédés de préparation de ces derniers ainsi qu'à des procédés permettant de les utiliser, seuls ou en combinaison avec d'autres agents thérapeutiques, comme agents thrombolytiques pour inhiber l'agrégation plaquettaire, et/ou pour le traitement de troubles thromboemboliques.
Batt Douglas Guy
Cain Gary Avonn
Degrado William Frank
Olson Richard Eric
Pinto Donald Joseph Phillip
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
LandOfFree
Novel isoxazoline and isoxazole fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel isoxazoline and isoxazole fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel isoxazoline and isoxazole fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1432462